Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
0.7683
-0.0315 (-3.94%)
At close: Sep 10, 2026, 4:00 PM EDT
0.7578
-0.0105 (-1.37%)
After-hours: Sep 10, 2026, 7:56 PM EDT
Company Description
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.
The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients.
The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021.
Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Nuwellis, Inc.
| Country | United States |
| Founded | 1999 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 38 |
| CEO | Michael McCormick |
Contact Details
Address: 12988 Valley View Road Eden Prairie, Minnesota 55344 United States | |
| Phone | 952 345 4200 |
| Website | nuwellis.com |
Stock Details
| Ticker Symbol | NUWE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001506492 |
| CUSIP Number | 67113Y801 |
| ISIN Number | US67113Y8012 |
| Employer ID | 68-0533453 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Michael Kendrick McCormick | President, Chief Executive Officer and Director |
| Neil P. Ayotte Esq. | Senior Vice President, General Counsel, Secretary and Chief Compliance Officer |
| Carisa Schultz | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer |
| David Lerner | Chief Technology Officer |
| Leah McMullen | Director of Communications |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 26, 2026 | EFFECT | Notice of Effectiveness |
| Aug 26, 2026 | 424B3 | Prospectus |
| Aug 26, 2026 | 8-K | Current Report |
| Aug 18, 2026 | S-3 | Registration statement under Securities Act of 1933 |
| Aug 14, 2026 | SCHEDULE 13G/A | Filing |
| Aug 13, 2026 | 8-K | Current Report |
| Aug 13, 2026 | 10-Q | Quarterly Report |
| Aug 7, 2026 | SCHEDULE 13G | Filing |
| Aug 6, 2026 | SCHEDULE 13G | Filing |
| Aug 5, 2026 | SCHEDULE 13G | Filing |